SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-062640
Filing Date
2017-10-18
Accepted
2017-10-18 06:04:02
Documents
3
Period of Report
2017-10-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-24012_28k.htm 8-K 22533
2 EX-99.1 a17-24012_2ex99d1.htm EX-99.1 24882
3 GRAPHIC g240122mmi001.jpg GRAPHIC 2861
  Complete submission text file 0001104659-17-062640.txt   52594
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 171141706
SIC: 2834 Pharmaceutical Preparations